Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 12, 2011, Pages 1849-1857

  Morita, Ryo ^a   Sato, Kazuhiro ^a   Nakano, Mariko ^a   Miura, Hajime ^a   Odaka, Hidesato ^a   Nobori, Kiyoshi ^a   Kosaka, Toshimitsu ^a   Sano, Masaaki ^a   Watanabe, Hiroyuki ^a   Shioya, Takanobu ^a   Ito, Hiroshi ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Endothelial progenitor cell; Non small cell lung cancer; Tumor angiogenesis; VEGF progression free survival

Indexed keywords

CARBOPLATIN; CD133 ANTIGEN; CD34 ANTIGEN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE; INTERLEUKIN 8; MONOCLONAL ANTIBODY; PEMETREXED; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CELL COUNT; CELL LABELING; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-8; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82955240682     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1043-8     Document Type: Article

References (32)

1. L Angelo R Kurzrock 2007 Vascular endothelial growth factor and its relationship to inflammatory mediators Clin Cancer Res 13 2825 2830 17504979 10.1158/1078-0432.CCR-06-2416 1:CAS:528:DC%2BD2sXlt1Kku7k%3D (Pubitemid 46849555)
2. LS Angelo R Kurzrock 2007 Vascular endothelial growth factor and its relationship to inflammatory mediators Clin Cancer Res 13 2825 2830 17504979 10.1158/1078-0432.CCR-06-2416 1:CAS:528:DC%2BD2sXlt1Kku7k%3D (Pubitemid 46849555)
3. T Asahara T Murohara A Sullivan M Silver R Zee T Li, et al. 1997 Isolation of putative progenitor endothelial cells for angiogenesis Science 275 964 967 9020076 10.1126/science.275.5302.964 1:CAS:528:DyaK2sXht1Clu7k%3D (Pubitemid 27087709)
4. T Asahara H Masuda T Takahashi C Kalka C Pastore M Silver, et al. 1999 Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 221 228 10436164 1:CAS:528:DyaK1MXltFGgs7Y%3D (Pubitemid 29377293)
5. L Boldrini S Gisfredi S Ursino M Lucchi A Mussi F Basolo, et al. 2005 Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations Lung Cancer 50 309 317 16125276 10.1016/j.lungcan.2005.07. 002
6. LF Brown B Berse RW Jackman K Tognazzi AJ Guidi HF Dvorak, et al. 1995 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer Hum Pathol 26 86 91 7821921 10.1016/0046-8177(95)90119-1 1:STN:280:DyaK2M7it1SktQ%3D%3D
7. RM Bukowski 2006 Randomized trial of bevacizumab in advanced renal cell carcinoma Curr Oncol Rep 10 99 100 10.1007/s11912-008-0016-9
8. B Dome J Timar J Dobos L Meszaros E Raso S Paku, et al. 2006 Identification and clinical significance of circulating endothelial progenitor cells in human non small cell lung cancer Cancer Res 66 7341 7347 16849585 10.1158/0008-5472.CAN-05-4654 1:CAS:528:DC%2BD28XmvFGkurs%3D (Pubitemid 44197717)
9. B Dome MJC Hendrix S Paku, et al. 2007 Alternative vascularization mechanisms in cancer Am J Pathol 170 1 15 17200177 10.2353/ajpath.2007.060302 1:CAS:528:DC%2BD2sXhsV2gtbw%3D (Pubitemid 47339184)
10. N Ferrara 2001 Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol 280 1358 1366
11. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581 611 15294883 10.1210/er.2003-0027 1:CAS:528:DC%2BD2cXns1Ght74%3D (Pubitemid 39099316)
12. J Folkman K Watson D Ingber D Hanahan, et al. 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 58 61 2469964 10.1038/339058a0 1:STN:280:DyaL1M3jvVGntg%3D%3D (Pubitemid 19115892)
13. M George G Tutton F Janssen A Arnaout AM Abulafi SA Eccles, et al. 2001 VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression Neoplasia 3 420 427 11687953 10.1038/sj.neo.7900186 1:CAS:528:DC%2BD3MXot1Sluro%3D (Pubitemid 32988812)
14. C Gridelli A Rossi P Maione 2003 Treatment of non small cell lung cancer state of the art and development of new biologic agent Oncogene 22 6629 6638 14528288 10.1038/sj.onc.1206957 1:CAS:528:DC%2BD3sXnsl2rsL8%3D (Pubitemid 37372343)
15. RS Herbst A Onn A Sandler 2005 Angiogenesis and lung cancer: prognostic and therapeutic implications J Clin Oncol 3 3243 3256 10.1200/JCO.2005.18.853 (Pubitemid 46211349)
16. RS Herbst VJ O'Neill L Fehrenbacher CP Belani PD Bonomi L Hart, et al. 2007 Phase II study of efficacy and safety of bevacizumab in Combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small cell lung cancer J Clin Oncol 25 4743 4750 17909199 10.1200/JCO.2007.12.3026 1:CAS:528:DC%2BD2sXhtlCgsLnP (Pubitemid 350086476)
17. W Hilbe S Dirnhofer F Oberwasserlechner T Schmid E Gunsilius G Hilbe E Woll CM Kaher 2004 CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non small cell lung cancer J Clin Pathol 57 965 969 15333659 10.1136/jcp.2004.016444 1:STN:280:DC%2BD2cvivVCgtA%3D%3D (Pubitemid 39208249)
18. M Hristov W Erl PC Weber 2003 Endothelial progenitor cells: isolation and characterization Trends Cardiovasc Med 13 201 206 12837583 10.1016/S1050- 1738(03)00077-X 1:CAS:528:DC%2BD3sXkvF2js74%3D (Pubitemid 36802024)
19. A Inoue T Suzuki T Fukuhara M Maemondo Y Kimura N Morikawa, et al. 2006 Prospective phase II study of gefitinib for chemotherapy naïve patients with advanced non small cell lung cancer with epidermal growth factor receptor gene mutation J Clin Oncol 24 3340 3346 16785471 10.1200/JCO.2005.05.4692 1:CAS:528:DC%2BD28Xot1Kis7g%3D (Pubitemid 46638887)
20. S Khan MA Solomon JP McCoy 2005 Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry Cytometry B Clin Cytom 64 1 8 15668988 (Pubitemid 40960406)
21. E Kim V Hirsh T Mok MA Socinski R Gervais YL Wu, et al. 2008 Gefitinib versus docetaxel in previously treated non small cell lung cancer (INTEREST): a randomized phase III trial Lancet 372 1809 1818 19027483 10.1016/S0140-6736(08) 61758-4 1:CAS:528:DC%2BD1cXhsVWhtbjM
22. D Lyden K Hattori S Dias C Costa P Blaikie A Chadburn, et al. 2001 Impaired recruitment of bone marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 1194 1201 11689883 10.1038/nm1101-1194 1:CAS:528:DC%2BD3MXotlKltLY%3D (Pubitemid 33063774)
23. M Maemondo A Inoue K Kobayashi S Sugawara S Oizumi H Isobe, et al. 2010 Gefitinib or chemotherapy for non small cell lung cancer with mutated EGFR N Engl J Med 365 2380 2388 10.1056/NEJMoa0909530
24. P Mancuso A Burlini G Pruneri A Goldhisch G Martinelli F Bertolini, et al. 2001 Resting and activated endothelial cells are increased in the peripheral blood of cancer patients Blood 97 3658 3661 11369666 10.1182/blood.V97.11.3658 1:CAS:528:DC%2BD3MXktFOku7k%3D
25. K Miller M Wang J Gralow M Dickler M Cobleigh EA Perez, et al. 2007 Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer N Engl J Med 357 2666 2676 18160686 10.1056/NEJMoa072113 1:CAS:528: DC%2BD1cXisVOnsg%3D%3D
26. B Namdarian KV Tan MJ Fankhauser TT Nguyen NM Corcoran AJ Costello, et al. 2010 Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma BJU Int 106 1081 1087 20201835 10.1111/j.1464-410X.2010. 09245.x 1:CAS:528:DC%2BC3cXhsVSks77O
27. K Nowak N Rafat S Belle C Weiss C Hanusch P Hohenberger, et al. 2010 Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease Eur J Cardiothorac Surg 37 758 763 19896859 10.1016/j.ejcts.2009.10.002
28. U Pastorino S Andreola E Taglibue F Pezzella M Incarbone G Sozzi, et al. 1997 Immunocytochemical markers in stage I lung cancer: relevance to prognosis J Clin Oncol 15 2858 2865 9256129 1:STN:280:DyaK2szpvVajtg%3D%3D (Pubitemid 27330013)
29. S Rafii D Lyden R Benezra K Hattori B Heissig 2002 Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2 826 835 12415253 10.1038/nrc925 1:CAS:528:DC%2BD38Xotlert7o%3D (Pubitemid 37328901)
30. M Roselli TC Mineo S Basili S Mariotti F Martini A Bellotti, et al. 2003 Vascular endothelial growth factor (VEGF-A) plasma levels in non small cell lung cancer: relationship with coagulation and platelet activation markers Thromb Haemost 89 177 184 12540968 1:CAS:528:DC%2BD3sXhvFentrg%3D (Pubitemid 36149807)
31. A Sandler 2007 Bevacizumab in non small cell lung cancer Clin Cancer Res 13 4613 4616 10.1158/1078-0432.CCR-07-0647 (Pubitemid 47219734)
32. Y Takahashi Y Kitadai CD Bucana KR Cleary LM Ellis, et al. 1995 Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res 55 3964 3968 7664263 1:CAS:528:DyaK2MXotV2msLg%3D